About Tethys BioScience
Tethys BioScience is a company based in Emeryville (United States) founded in 2002. It operates as a B2B. Tethys BioScience has raised $53.3 million across 5 funding rounds from investors including SVB, Kleiner Perkins and Oxford Finance. The company has 81 employees. Tethys BioScience has completed 1 acquisition, including Lipomics. Tethys BioScience operates in a competitive market with competitors including Viome Life Sciences, Proteomics International, Mellitus, SmartZyme and Veralight, among others.
- Headquarter Emeryville, United States
- Employees 81
- SectorsHealthcare
- Website tethysbio.com
- Social Facebook
- Legal Name Tethys Bioscience, Inc
Funding Insights of Tethys BioScience
Tethys BioScience has successfully raised a total of $53.3M across 5 strategic funding rounds. The most recent funding activity was a Series D round of $23 million completed in July 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $53.3M
- Total Rounds 5
- Last Round Series D — $23M
- First Round $5.3M
(Jun 2005)
- Investors Count 9
All 5 funding rounds of Tethys BioScience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2010 | $10M | Debt – Conventional | – | – | |
| Jul 2010 | $23M | Series D | – | Greenspring Associates, Paul Capital | |
| Nov 2009 | $25M | Series D | – | Calibrium | |
| Jan 2008 | – | Series C | – | Intel Capital | |
| Jun 2005 | $5.3M | Series A | – | – |
9 investors in total: 9 institutional.
Investors in Tethys BioScience
Tethys BioScience has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, Kleiner Perkins and Oxford Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture debt firm focused on the life sciences sector | 2002 | oxfordfinance.com | Alexandria, United States | |
Diversified investment management firm | 2000 | greenspringassociates.com | Owings Mills, United States | |
Investment in technology startups focusing on compute, AI, and related innovations. | – | intelcapital.com | - | |
Venture capital investments are managed in technology and healthcare sectors by this firm. | – | mdv.com | - | |
Venture capital firm investing in early-stage tech startups | 1972 | kleinerperkins.com | Menlo Park, United States | |
Banking services are provided to innovative companies, investors, and individuals. | 1983 | svb.com | Santa Clara, United States | |
Functions as a diversified investor in secondary markets. | 1991 | paulcap.com | San Francisco, United States | |
Private investment services are offered by Calibrium for clients. | – | clbrm.com | Zürich, Switzerland | |
Provides active investment management for small-cap equities worldwide. | 1975 | wasatchglobal.com | Salt Lake City, United States |
Investor details for Tethys BioScience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Tethys BioScience
5 people are tracked at Tethys BioScience (2 in leadership, 3 in team); the tracked headcount is 81.
| Name | Role | Group |
|---|---|---|
Randy Strahan | President/CEO | Leadership |
Janice Kolberg | VP Clinical Research | Leadership |
Neal Murakami | Accounting Manager | Team |
Claudia Elkin | CLS | Team |
Cathi Dall | Medical Billing Specialist | Team |
Complete people profiles for Tethys BioScience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Tethys BioScience
Tethys BioScience has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Lipomics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Diagnostics for metabolic, cardiovascular, and inflammatory conditions are developed. | lipomics.com | Sacramento, United States | 2000 | Sep 2008 | •••• |
Complete acquisition details for Tethys BioScience
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Tethys BioScience
4 dated milestones of Tethys BioScience across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Tethys BioScience is founded.
- Funding First funding round of $5.3M.
- Acquisition Acquires Lipomics.
- Funding Latest funding round, Series D, of $23.0M.
Competitors of Tethys BioScience
Tethys BioScience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome Life Sciences, Proteomics International, Mellitus, SmartZyme and Veralight, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viomelifesciences.com | 2016 | Bothell, United States | $92.44M | 136 | Provider of tests to prevent, treat, and cure chronic diseases, and cancer | |
| proteomics.com.au | 2001 | Perth, Australia | – | – | Medical technology company at the forefront of predictive diagnostics and bio-analytical services | |
| mellitusllc.com | 2011 | Boston, United States | $16.1M | – | In vitro diagnostic test for Gestational Diabetes Mellitus (GDM) | |
| smzyme.com | 2013 | Herzliya Pituach, Israel | $4M | – | Proprietary protein engineering technology is developed for diabetes products. | |
| thescoutds.com | 2004 | Albuquerque, United States | $25.23M | – | Offers biomarker screening solutions for early diabetes detection. | |
| sensotrend.com | 2013 | Tampere, Finland | – | – | Automated diabetes diary is offered for blood sugar monitoring. | |
| accessiblediagnostics.com | 2014 | Greenville, United States | $548,500 | – | Delivers comprehensive glucose monitoring device solutions. | |
| patiadiabetes.com | 2013 | Mexico | – | – | Genetic tests for type 2 diabetes risk assessment are developed. |
Detailed competitors of Tethys BioScience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Tethys BioScience
Websites that share an audience with Tethys BioScience (tethysbio.com).
Websites whose visitors overlap most with Tethys BioScience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| hdlabinc.com | 100% | – | – | View details |
Latest news on Tethys Bioscience
Complete news archive for Tethys BioScience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Tethys BioScience
10 companies that operate in the same segment as Tethys BioScience (Clinical Genomics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Panomic profiling technologies are developed for cancer precision medicine. | 1996 | Irving, Texas, United States | USD 1.23 B | – | 1,339 | |
Genomics-based diagnostic tests for cancer are provided. | 2010 | Cambridge, Massachusetts, United States | USD 96.5 M | – | – | |
Digital molecular biology analytics are developed for disease management. | 2012 | Carlsbad, California, United States | USD 95.02 M | – | 46 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Genomic database for clinical research is provided. | 2015 | San Francisco, California, United States | USD 435 M | – | – | |
Genomic sequencing and diagnosis software is provided for healthcare. | 2011 | Menlo Park, California, United States | USD 87.3 M | USD 69.65 M | 229 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Tethys BioScience
Tethys BioScience was founded in 2002 and raised its 1st funding round 3 years after it was founded.
Tethys BioScience is headquartered in Emeryville, United States. It is registered at Emeryville, California, United States.
Tethys BioScience is a funded company, having raised a total of $53.3M across 5 funding rounds to date. The company's 1st funding round was a Series A of $5.3M, raised on Jun 2005.
Tethys BioScience has 81 employees.
Tethys BioScience develops biological markers for medical diagnostic applications through providing healthcare solutions, advancing biotech innovations, offering diagnostic solutions, and biomarkers. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Tethys BioScience's top competitors include Viome Life Sciences, Proteomics International and Mellitus.
Tethys BioScience has made 1 acquisition, including Lipomics.
Tethys BioScience has 9 investors. Key investors include SVB, Kleiner Perkins, Oxford Finance, Greenspring Associates, and Paul Capital.
Tethys BioScience operates through Tethys Bioscience, Inc.